BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20374252)

  • 21. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
    Nakano T; Petrash JM
    Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P-Glycoprotein (P-gp) expressed in a confluent monolayer of hMDR1-MDCKII cells has more than one efflux pathway with cooperative binding sites.
    Acharya P; Tran TT; Polli JW; Ayrton A; Ellens H; Bentz J
    Biochemistry; 2006 Dec; 45(51):15505-19. PubMed ID: 17176072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential inhibition of cytosolic PEPCK by substrate analogues. Kinetic and structural characterization of inhibitor recognition.
    Stiffin RM; Sullivan SM; Carlson GM; Holyoak T
    Biochemistry; 2008 Feb; 47(7):2099-109. PubMed ID: 18197707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
    Murphy MJ
    Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and evaluation of 9-D-ribitylamino-1,3,7,9-tetrahydro-2,6,8-purinetriones bearing alkyl phosphate and alpha,alpha-difluorophosphonate substituents as inhibitors of tiboflavin synthase and lumazine synthase.
    Cushman M; Sambaiah T; Jin G; Illarionov B; Fischer M; Bacher A
    J Org Chem; 2004 Feb; 69(3):601-12. PubMed ID: 14750781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probing the active site of rat porphobilinogen synthase using newly developed inhibitors.
    Li N; Chu X; Liu X; Li D
    Bioorg Chem; 2009 Feb; 37(1):33-40. PubMed ID: 19095280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzyme/non-enzyme discrimination and prediction of enzyme active site location using charge-based methods.
    Bate P; Warwicker J
    J Mol Biol; 2004 Jul; 340(2):263-76. PubMed ID: 15201051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel approach to predict active sites of enzyme molecules.
    Chou KC; Cai YD
    Proteins; 2004 Apr; 55(1):77-82. PubMed ID: 14997541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Jack bean urease: the effect of active-site binding inhibitors on the reactivity of enzyme thiol groups.
    Krajewska B; Zaborska W
    Bioorg Chem; 2007 Oct; 35(5):355-65. PubMed ID: 17418881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The competition plot: A kinetic method to assess whether an enzyme that catalyzes multiple reactions does so at a unique site.
    Cárdenas ML
    Methods; 2001 Jun; 24(2):175-80. PubMed ID: 11384192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect.
    Szegletes T; Mallender WD; Thomas PJ; Rosenberry TL
    Biochemistry; 1999 Jan; 38(1):122-33. PubMed ID: 9890890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2-Alkylmalonic acid: amphiphilic chelator and a potent inhibitor of metalloenzyme.
    Ojha B; Singh AK; Adhikari MD; Ramesh A; Das G
    J Phys Chem B; 2010 Aug; 114(33):10835-42. PubMed ID: 20669918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic evidence for an anion binding pocket in the active site of nitronate monooxygenase.
    Francis K; Gadda G
    Bioorg Chem; 2009 Oct; 37(5):167-72. PubMed ID: 19683782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statistical Mechanics of Allosteric Enzymes.
    Einav T; Mazutis L; Phillips R
    J Phys Chem B; 2016 Jul; 120(26):6021-37. PubMed ID: 27070509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-molecule enzyme kinetics in the presence of inhibitors.
    Saha S; Sinha A; Dua A
    J Chem Phys; 2012 Jul; 137(4):045102. PubMed ID: 22852658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversible inhibition of enzymatic systems involving covalent intermediates.
    Zhao GH; Frère JM
    J Enzyme Inhib; 1997 Feb; 11(4):245-64. PubMed ID: 9208368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protocol for rational design of covalently interacting inhibitors.
    Schmidt TC; Welker A; Rieger M; Sahu PK; Sotriffer CA; Schirmeister T; Engels B
    Chemphyschem; 2014 Oct; 15(15):3226-35. PubMed ID: 25251382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single molecule enzymology: watching the reaction.
    Gershenson A
    Curr Opin Chem Biol; 2009 Oct; 13(4):436-42. PubMed ID: 19632886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixed and non-competitive enzyme inhibition: underlying mechanisms and mechanistic irrelevance of the formal two-site model.
    Pesaresi A
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2245168. PubMed ID: 37577806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusional correlations among multiple active sites in a single enzyme.
    Echeverria C; Kapral R
    Phys Chem Chem Phys; 2014 Apr; 16(13):6211-6. PubMed ID: 24562416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.